Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
NCT03123887
·
clinicaltrials.gov ↗
COMPLETED
Status
632
Enrollment
OTHER
Sponsor class
Conditions
B-precursor Acute Lymphoblastic Leukemia
Interventions
OTHER:
salvage therapy
Sponsor
Harbin Hematology and Oncology Institute